248 related articles for article (PubMed ID: 30986362)
21. Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
Nelson AJ; O'Brien EC; Kaltenbach LA; Green JB; Lopes RD; Morse CG; Al-Khalidi HR; Aroda VR; Cavender MA; Gaynor T; Kirk JK; Lingvay I; Magwire ML; McGuire DK; Pak J; Pop-Busui R; Richardson CR; Senyucel C; Kelsey MD; Pagidipati NJ; Granger CB
JAMA Netw Open; 2022 Feb; 5(2):e2148030. PubMed ID: 35175345
[TBL] [Abstract][Full Text] [Related]
22. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us.
Catalán-Ramos A; Verdú JM; Grau M; Iglesias-Rodal M; del Val García JL; Consola A; Comin E;
Aten Primaria; 2014 Jan; 46(1):15-24. PubMed ID: 24325864
[TBL] [Abstract][Full Text] [Related]
23. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
24. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic.
Chmelík Z; Vaclová M; Lánská V; Laštůvka J; Vrablík M
Cent Eur J Public Health; 2020 Jun; 28(2):114-119. PubMed ID: 32592555
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
[TBL] [Abstract][Full Text] [Related]
26. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
Boels AM; Hart HE; Rutten GE; Vos RC
Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
[TBL] [Abstract][Full Text] [Related]
27. Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care.
Ambrož M; Geelink M; Smits KPJ; de Vries ST; Denig P
Diabet Med; 2023 Jan; 40(1):e14987. PubMed ID: 36278892
[TBL] [Abstract][Full Text] [Related]
28. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
Briskman I; Bar G; Boaz M; Shargorodsky M
Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
[TBL] [Abstract][Full Text] [Related]
29. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
[TBL] [Abstract][Full Text] [Related]
30. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
[TBL] [Abstract][Full Text] [Related]
31. The relationship between socioeconomic deprivation and metabolic/cardiovascular risk factors in a cohort of patients with type 2 diabetes mellitus.
O'Kane MJ; McMenamin M; Bunting BP; Moore A; Coates VE
Prim Care Diabetes; 2010 Dec; 4(4):241-9. PubMed ID: 20869343
[TBL] [Abstract][Full Text] [Related]
32. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Gaede P; Vedel P; Larsen N; Jensen GV; Parving HH; Pedersen O
N Engl J Med; 2003 Jan; 348(5):383-93. PubMed ID: 12556541
[TBL] [Abstract][Full Text] [Related]
33. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB
Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549
[No Abstract] [Full Text] [Related]
34. Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.
Hasvold LP; Bodegård J; Thuresson M; Stålhammar J; Hammar N; Sundström J; Russell D; Kjeldsen SE
J Hum Hypertens; 2014 Nov; 28(11):663-9. PubMed ID: 25211055
[TBL] [Abstract][Full Text] [Related]
35. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
[TBL] [Abstract][Full Text] [Related]
36. Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Liu CH; Lee TH; Lin YS; Sung PS; Wei YC; Li YR
Cardiovasc Diabetol; 2020 Jan; 19(1):2. PubMed ID: 31910836
[TBL] [Abstract][Full Text] [Related]
37. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
Sun X; Du T
BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
[TBL] [Abstract][Full Text] [Related]
38. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
39. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
40. [Dynamics of prevalence of arterial hypertension and other risk factors of development of cardiovascular diseases in female population of Tallin (10 year prospective study)].
Shipilova T; Pshenichnikov I; Abina E; Karaĭ D; Ripul'k E; Veski K; Pil't K; Meĭgas K; Kaĭk Iu
Kardiologiia; 2010; 50(11):40-6. PubMed ID: 21526563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
